Characteristic | All Patients | Supervision per day | Dependence Level | |||
---|---|---|---|---|---|---|
≤ 12 hrs | > 12 hrs | < 3 | ≥ 3 | |||
Number | 1287 | 407 | 880 | 692 | 595 | |
Socio-demographic details | ||||||
Age, (years) | Mean (SD) | 73.8 (8.3) | 72.9 (8.5) | 74.2 (8.2)* | 72.1 (8.6) | 75.8 (7.5)* |
Female | N (%) | 801 (62) | 261 (64.1) | 540 (61.4) | 388 (56.1) | 413 (69.4)* |
Education beyond elementary school | N (%) | 876 (68.8) | 271 (67.6) | 605 (69.3) | 508 (74.1) | 368 (62.6)* |
Lives with caregiver | N (%) | 934 (74.2) | 203 (51.5) | 731 (84.5)* | 496 (73.0) | 438 (75.5) |
Spouse or partner caregiver | N (%) | 781 (62.1) | 175 (43.0) | 606 (68.9)* | 431 (62.3) | 350 (58.8) |
Clinical characteristics | ||||||
Time since onset of cognitive problems, (years) | Mean (SD) | 3.8 (2.6) | 3.6 (2.6) | 3.9 (2.6)* | 3.7 (2.6) | 4.0 (2.6)* |
Time since AD diagnosis (years) | Mean (SD) | 1.0 (1.4) | 0.9 (1.2) | 1.1 (1.4) | 0.9 (1.3) | 1.1 (1.4)* |
Extra-pyramidal symptoms | N (%) | 68 (5.2) | 15 (3.7) | 53 (6.0) | 29 (4.2) | 39 (6.6) |
Anti-psychotic medication | N (%) | 328 (25.5) | 81 (19.9) | 247 (28.1)* | 134 (19.3) | 194 (32.6)* |
MMSE | Mean (SD) | 19.3 (3.7) | 20.4 (3.4) | 18.8 (3.8)* | 20.5 (3.3) | 18.0 (3.8)* |
ADAS-cog | Mean (SD) | 25.4 (10.4) | 22.7 (9.7) | 26.7 (10.5)* | 22.0 (8.7) | 29.5 (10.8)* |
Dependence | ||||||
Dependence level >= 3 | N (%) | 583 (46.0) | 134 (32.9) | 461 (52.4) | ||
DAD | Mean (SD) | 70.1 (22.5) | 77.7 (20.0) | 66.7 (22.7)* | 81.9 (14.9) | 56.3 (22.0)* |